Eisai: Gilead Sciences Submits New Drug Application in Japan for Filgotinib for the Treatment of Ulcerative Colitis with an Inadequate Response to Conventional Therapies
- Written by ACN Newswire - Press Releases
Read more //?#
.
“Time is running out to get Payday ready,” Brighter Super urges
Superannuation fund Brighter Super is encouraging business owners to prepare now for Payday Super, ahead of the new laws taking effect from 1 July...
PayNuts Unveils Expanded Integrated Solutions and Refreshed Brand to Support Australian SMEs
PayNuts, one of Australia’s fastest-growing payment service providers, has unveiled a refreshed brand identity and an expanded suite of integrated b...
BizCover Brings Australia’s First AI-Based Insurance Quotes to ChatGPT
Australian small business owners can now receive and compare business insurance quotes directly inside ChatGPT, in a move that signals a major shi...
VistaPrint Research Reveals Australian Small Businesses Face a Succession Cliff
With only 16% of retiring small businesses having a succession plan, tens of thousands risk closure as one in three owners nears retirement. Ne...
Corporate volunteering grows up: how companies are shifting to meaningful, community-led impact
As workplaces settle into the new year and look for ways to strengthen culture, capability and connection, experts say corporate volunteering is e...
The Rise of Mobile-First Venues
Global Hospitality Platform, Tabit, Reveals Five Ways to Maximise Benefits of Mobile-First Systems As Australian hospitality venues grapple with...